Interim analysis [Study As­sess­ment]

posted by Ohlbe – France, 2014-10-15 01:53 (3862 d 14:42 ago) – Posting: # 13709
Views: 7,017

Dear Samaya,

❝ When data for first half subjects (N: 28) was analysed, we got following results.

❝ Cmax ratio: 87 (CI: 80.88-95.13)

❝ AUC ratio: 87 (CI: 81.85-94.18)


Did you plan for a two-stage design (which I understand is tricky for full replicate studies) ? If so, why proceed to the second stage though BE was demonstrated ? If not, then what was the reason for doing an interim analysis ? Was it planned in the protocol (with appropriate alpha-correction) ?

Regards
Ohlbe

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,671 registered users;
178 visitors (0 registered, 178 guests [including 9 identified bots]).
Forum time: 16:35 CEST (Europe/Vienna)

If you shut your door to all errors
truth will be shut out.    Rabindranath Tagore

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5